Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy
Clinical trial NCT06502990 · TERMINATED
Trial details
- NCT number
- NCT06502990
- Sponsor
- Amryt Pharma
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-23
- Primary completion
- 2026-02-11
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.